Evaluation of the insulin application system Autopen 24®

Practical Diabetes International

Volumn 22, Issue 9, 2005, Pages 364-366a

  Larbig, Martin ^a   Forst, Thomas ^a   Forst, Senait ^a   Lorra, Babette ^b   König, Kerstin ^b   Fittkau, Torsten ^c   Pfützner, Andreas ^a  

^a IKFE Institute for Clinical Research and Development   (Germany)

^b Owen Mumford GmbH ^*

^c Owen Mumford GmbH   (Germany)

Author keywords

Autopen 24; Insulin pen; Insulin therapy; Patient self injection

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEVICE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INTERMETHOD COMPARISON; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OPEN STUDY; RANDOMIZED CONTROLLED TRIAL;

EID: 34250876230     PISSN: 13578170     EISSN: 1528252X     Source Type: Journal    
DOI: 10.1002/pdi.877     Document Type: Article

References (11)

1. Goldstein DE, Little RR, Wiedmeyer HM, et al. Is glcohemoglobin testing useful in diabetes mellitus? Lessons from the Diabetes Control and Complications Trial. Clin Chem 1994; 40: 1637-1640.
2. Turner RC. The UK Prospective Diabetes Study. A review. Diabetes Care 1998; 21 (Suppl 3): C35-C38.
3. Bohannon NJ. Insulin delivery using pen devices. Simple-to-use tools may help young and old alike. Postgrad Med 199; 106: 57-58, 61-64, 68.
4. King L. Subcutaneous insulin injection technique. Nurs Stand 2003; 17: 45-52.
5. de Luis DA, Aller R, Cuellar L, et al.. Effect on quality of life with a new insulin injection device in elderly patients with diabetes mellitus type 2. Diabetes Complications 2004; 18: 216-219.
6. Shelmet J, Schwartz S, Cappleman J, et al; InnoLet Study Group. Preference and resource utilization in elderly patients: InnoLet versus vial/syringe. Diabetes Res Clin Pract 2004; 63: 27-35.
7. Piscopo MA, Chiesa G, Bonfanti R, et al. Quality of life and new devices in the management of type 1 diabetes in children and adolescents. Acta Biomed Ateneo Parmense 2003; 74 (Suppl 1): 21-25.
8. Lteif AN, Schwenk WF. Accuracy of pen injectors versus insulin syringes in children with type 1 diabetes. Diabetes Care 1999; 22: 137-140.
9. Summers KH, Szeinbach SL, Lenox SM. Preference for insulin delivery systems among current insulin users and nonusers. Clin Ther 2004; 26: 1498-1505.
10. Graff MR, McClanahan MA. Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe. Clin Ther 1998; 20: 486-496.
11. Martin JM, Llewelyn JA, Ristic S, et al. Acceptability and safety of a new 3.0ml re-usable insulin pen (HumanPen) in clinical use. Diabetes Nutr Metab 1999; 12: 306-309.